Cero Therapeutics Files 8-K: Material Agreements & Equity Sales
Ticker: CEROW · Form: 8-K · Filed: Apr 22, 2025 · CIK: 1870404
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
Related Tickers: CERO
TL;DR
Cero Therapeutics filed an 8-K on April 21, 2025, reporting material agreements and unregistered equity sales.
AI Summary
On April 21, 2025, Cero Therapeutics Holdings, Inc. filed an 8-K report detailing several key events. The company entered into a material definitive agreement, engaged in unregistered sales of equity securities, and reported other events. The filing also included financial statements and exhibits, with the report being filed as of April 22, 2025.
Why It Matters
This filing indicates significant corporate actions, including potential new financing or partnerships and equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Registrant
- April 21, 2025 (date) — Date of earliest event reported
- April 22, 2025 (date) — Date filed
- Delaware (jurisdiction) — State of incorporation
- 001-40877 (identifier) — SEC File Number
FAQ
What was the nature of the material definitive agreement entered into by Cero Therapeutics Holdings, Inc. on April 21, 2025?
The filing does not specify the details of the material definitive agreement, only that one was entered into.
What type of equity securities were sold in the unregistered sales reported by Cero Therapeutics Holdings, Inc.?
The filing mentions unregistered sales of equity securities but does not specify the type or details of these securities.
What are the key financial statements and exhibits included in this 8-K filing?
The filing states that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
When was Cero Therapeutics Holdings, Inc. formerly known as Phoenix Biotech Acquisition Corp.?
The company's name was changed from Phoenix Biotech Acquisition Corp. on June 30, 2021.
What is the SIC code for Cero Therapeutics Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Cero Therapeutics Holdings, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 22, 2025 regarding CERO THERAPEUTICS HOLDINGS, INC. (CEROW).